Confluence at Three Springs

Confluence at Three Springs

Durango, Colorado

Description

Newly constructed, 98% occupied, Class “A” stabilized multifamily residential complex. This property has an attractive in-place cash flow in a supply-constrained, high-growth, and high barrier-to-entry market.

Significant purchase price discount with stabilized below replacement cost in an undersupplied market with projected population growth.

image

Details

Target Equity Multiple: 1.9x

Target IRR: 15%

Deal Type: Core+

Asset Type: Multifamily

Sponsor: Trailbreak Partners

Target Investment Period: 6 years

More Portfolio Properties

200 West Jackson, Chicago, Illinois

Office | Core+ | Target IRR 19%

Solace on Peachtree, Atlanta, Georgia

Multifamily | Value-add | Target IRR 18%

East Broad Street, Richmond, Virginia

Multifamily | Value-add | Target IRR 19%

The Joinery, Charlotte, North Carolina

Multifamily | Opportunistic | Target IRR 20%

32nd & Eliot Apartments, Denver, Colorado

Multifamily | Opportunistic | Target IRR 20%

The Waterford, Austin, Texas

Multifamily | Opportunistic | Target IRR 20%

19th & Chestnut, Denver, Colorado

Multifamily | Opportunistic | Target IRR 19%

Country Meadows, Madison, Wisconsin

Multifamily | Value-add | Target IRR 16%

Hampton Inn, Myrtle Beach, North Carolina

Hotel | Value-add | Target IRR 20%

The Wyndham Riverwalk, San Antonio, Texas

Hotel | Value-add | Target IRR 20%

Last Mile, Orlando, Florida

Industrial | Value-add | Target IRR 20%

Distribution Center, Bunsen, Kentucky

Industrial | Value-add | Target IRR

Medical Office Fund

Medical | Value-Add | Target IRR 18%

Boat & RV Storage, Nashville, TN & Charlotte, NC

Storage | Opportunistic | Target IRR 16%

The Hotel at Avalon, Alpharetta, Georgia

Hotel | Core+ | Target IRR 22%

Ashbury Court, Laurel, Maryland

Value-Add | Multifamily | Target IRR 15%

Micro-Unit Apartments, Washington, D.C

Opportunistic | Multifamily | Target IRR: 20.1%

Confluence at Three Springs, Durango, Colorado

Core+ | Multifamily | Target IRR: 15%

Biotechnology Lab, Cambridge, Massachusetts

Opportunistic | Property Type | Target IRR: 21.9%